You will move to an external webpage. Are you sure?

Nobelpharma

News & Press Release

  • 2024-01-18 Product Information

mTOR inhibitor “RAPRLIMUS®” Approved for Additional Indication for Tablets 1 mg and Additional Formulation of Granule 0.2%

  1. 前の記事へ
  2. 一覧へ戻る（英語）
  3. 次の記事へ
PAGE TOP
  1. HOME
  2. News & Press Release
  3. mTOR inhibitor “RAPRLIMUS®” Approved for Additional Indication for Tablets 1 mg and Additional Formulation of Granule 0.2%